GSK to Advance Innovative Liver Disease Treatment with Acquisition of Efimosfermin
GSK has announced its acquisition of efimosfermin alfa, a promising new medicine…
GSK and Flagship to jointly fund up to $150 million upfront
July 2024- GSK and Flagship Pioneering (Flagship) announced they have entered a…